The Swedish government intends to privatize its state pharmaceuticals retailing monopoly, Apoteket AB, in a series of moves rather than in one fell swoop.
Under plans outlined by Health Minister Goran Hagglund, Apoteket will remain as a key actor on a competitive market, with the majority of the pharmacies it currently controls remaining under state ownership, while the other premises will be sold. The transfer to new owners will be undertaken so as to ensure that access to new medicinal products is at least as good as it is at present.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze